Detalhes bibliográficos
| Ano de defesa: |
2016 |
| Autor(a) principal: |
Costa, Glaucio Carneiro
 |
| Orientador(a): |
Corr??a, Fernanda Ishida |
| Banca de defesa: |
Corr??a, Fernanda Ishida,
Silva, Soraia Micaela,
Carvalho, Regiane Albertini de |
| Tipo de documento: |
Dissertação
|
| Tipo de acesso: |
Acesso aberto |
| Idioma: |
por |
| Instituição de defesa: |
Universidade Nove de Julho
|
| Programa de Pós-Graduação: |
Programa de P??s-Gradua????o em Ci??ncias da Reabilita????o
|
| Departamento: |
Sa??de
|
| País: |
Brasil
|
| Palavras-chave em Português: |
|
| Palavras-chave em Inglês: |
|
| Área do conhecimento CNPq: |
|
| Link de acesso: |
http://bibliotecatede.uninove.br/handle/tede/1856
|
Resumo: |
The Glittre AVD test (TGlittre) is a specific test to evaluate functional limitation in patients with chronic obstructive pulmonary disease, but it is not known whether it can be used to assess the capacity and performance of post-stroke patients. Objectives: To analyze the validation of TGlittre construct for hemiparetic patients due to stroke. METHODS: construct validity was analyzed using classical psychometry that established the use of well defined statistical methods, 30 hemiparetic adults after stroke and 20 healthy adults, matched in gender and age, according to eligibility criteria. The results were correlated to the 6-min walk test (TC6), time up and go (TUG) and functional independence measure scale (MIF) to analyze construct validity. The tests were randomized, performed on two consecutive days by the same evaluator. Data were submitted to the Shapiro Wilk normality test. The time of execution of the test between the groups was compared by the Mann-Whitney test. RESULTS: There was a strong and significant correlation between the AVD-Glittre versus the 6MT (r = -0.91, p <0.001), TUG (r = 0.82, p <0.001) 0.47, p <0.008). Conclusions: The AVD-Glittre was valid for evaluation of functional capacity and performance of hemiparetic patients after stroke. The Glittre AVD test is reliable when correlated with other tests already validated under different health conditions. |
